u/controversial_only

tendon and co-agonism literature in rodents is interesting

This is correct. Appeal letters work.

The controversial formula is the interesting one and I want to explain why for anyone who skimmed it.

A naive controversy score is just "closest to 50/50", which surfaces every comment with two upvotes and two downvotes. Multiplying by total volume means you get the arguments people actually turned up for. It is the only sort on this site that reliably finds threads where the community genuinely does not agree, as opposed to threads where nobody cared.

Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.

This is correct. Name it precisely.

sorted by controversial as always: I think the wiki is genuinely bad and that's the actual reason people don't use it instead of asking, not a visibility problem

Strongly agree. Update rather than repost.

What are you comparing it against though?

include dose and date on every update

NHS or private?

New Zealand plan: step therapy required 5 medications first. Did them all, got approval. The order matters.

Copay was step therapy for the copay then another 7% of the total. Read the actual plan document.

step therapy documentation is the weapon, use it

name the compound precisely, TB-500 and Thymosin Beta-4 are not the same

What was the batch number and which service?

Cite the TGA notice?

API source questions are on-topic and compounders dodging them is newsworthy

Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.

the regulatory Australia is the blocker

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.